Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef2a6d661df17e57ad3155c24188735 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-529 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
filingDate |
1999-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a82535133a8a8fdf7c40c906d6642e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b21de198529dd5969747cdbb789acb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a2fccbf9915adbcd7acbdbc5b023db7 |
publicationDate |
2002-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2002179591-A |
titleOfInvention |
Intraocular pressure reducing agent |
abstract |
PROBLEM TO BE SOLVED: To provide a novel intraocular pressure lowering agent which has an excellent intraocular pressure lowering effect and has few side effects for application to prevention and / or treatment of glaucoma and ocular hypertension. . SOLUTION: An intraocular pressure lowering agent comprising a compound having a vasopressin V1 receptor antagonistic activity as an active ingredient. |
priorityDate |
1999-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |